Validity of the medical outcomes study sleep scale in patients with painful diabetic peripheral neuropathy in Korea
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q2
- 저널
- JOURNAL OF DIABETES INVESTIGATION4(4) · pp.405 · 2013
- 피인용
- Web of Science 23
- JCR IF
- JCR 2012 1.77
- ISSN
- 2040-1116
저자
- 김상수제1저자Department of Internal Medicine, Pusan National University Hospital, South Korea
- Won, Jong ChulDepartment of Internal Medicine, Cardiovascular and Metabolic Disease Centre, College of Medicine, Inje University, South Korea
- Kwon, Hyuk SangDepartment of Internal Medicine, College of Medicine, Catholic University of Korea, South Korea
- Kim, Chong HwaDepartment of Internal Medicine, Sejong General Hospital, South Korea
- Lee, Ji HyunDepartment of Internal Medicine, School of Medicine, Catholic University of Daegu, South Korea
- Park, Tae SunDepartment of Internal Medicine, Chonbuk National University Medical School, South Korea
- Ko, Kyung Soo교신저자Department of Internal Medicine, Cardiovascular and Metabolic Disease Centre, College of Medicine, Inje University, South Korea
- Cha, Bong YunDepartment of Internal Medicine, College of Medicine, Catholic University of Korea, South Korea
초록
Aims/Introduction: Sleep disturbances caused by painful diabetic neuropathy (PDN) might have substantial impacts on the multifaceted aspects of PDN, including quality of life. There are no convincing data on the validation or reliability of sleep problem measurements in patients with PDN in Korea. This large population-based cross-sectional study examined psychometric properties of the Medical Outcomes Study (MOS) Sleep Scale in patients with PDN in Korea. Materials and Methods: Measurements of patient-reported outcomes (Brief Pain Inventory-short form, MOS Sleep Scale and EuroQoL Health [EQ-5D]) were documented. PDN was diagnosed if the average daily pain intensity was >= 4 based on the visual analog scale or if patients were taking medication for their current pain. Results: There were 577 patients with PDN (41.6% with diabetic peripheral neuropathy). The internal consistency of reliability for the MOS Sleep Scale was 0.80 as measured by Cronbach's alpha. The extent to which multiple items in a dimension were intercorrelated and formed a dimension measuring the same underlying concept (Pearson's correlation coefficient) ranged from 0.24 to 0.71 (all P < 0.001). Each item of the MOS Sleep Scale was significantly correlated with the average pain score and the pain interference score (Pearson's correlation coefficients ranged from 0.20 to 0.28 and from 0.29 to 0.40, respectively; all P < 0.001). The correlations between the EQ-5D index and the MOS Sleep Scale ranged from -0.27 to -0.31 (all P < 0.001). Conclusions: The MOS Sleep Scale showed good reliability in the evaluation of PDN in Korean type 2 diabetic patients.
키워드
Diabetic neuropathiesPainSleepQUALITY-OF-LIFERELIABILITYPREVALENCESEVERITYEUROQOL
식별자
- WoS UID
- 000321346400014



로그인
연구물 목록으로